Company attributes
Venture Capital Firm attributes
Other attributes
International Biotechnology Trust is a private equity firm in London that offers investors access to the fast growing biotechnology sector through an actively managed fund. Founded 1994 in London, England, United Kingdom, this private equity firm invests in early stage ventures. Its portfolio companies include Karus Therapeutics, Sutro Biopharma, Aderis Pharmaceuticals, and eBioinformatics. International Biotechnology Trust has made four investments. Their most recent investment was on September 6, 2012, when Karus Therapeutics raised $7.6M. The company has had two exits, the most notable of which include Sutro Biopharma and Aderis Pharmaceuticals.
The company invests in biotechnology and other life sciences companies especially those which are engaged in on drug discovery and development, medical devices companies and healthcare services. They invest in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions.
